| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47ea433a38186d2b1995e5b23deb9564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4feda2a82a4adcd92a7619df2248333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50284d57d35b56e96e06ad3e16f12dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fbc150ff5f5e362bd61c6152a2c78f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb52da0e1597b902579ef2a6b09a4c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d7672744f2424011ebda85decbc4bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff552f506bf338735821f92da2c3dd91 |
| publicationDate |
1999-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9905301-A1 |
| titleOfInvention |
Gene transfer method with the use of serum-free medium |
| abstract |
A method for transferring a gene into target cells by a retrovirus with the use of a serum-free medium. This method comprises infecting target cells with a retrovirus in a serum-free medium optionally containing low-density lipoprotein and/or cytokines in the presence of a functional susbstance such as fibronectin in an amount effective in elevating the gene transfer efficiency of the retrovirus into the target cells when the retrovirus and the target cells are present together. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005019450-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4870432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017506511-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8975070-B2 |
| priorityDate |
1997-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |